Market Research Reports and Industry Reports

United States Influenza Vaccine Market, Vaccination Analysis, Distribution, Production, Pipeline Insights, Clinical Trials, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca, Protein Sciences Corporation, Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, VaxInnate "United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.
 
 Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.
 
 The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.
 
 The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.
 
 Major and Promising Vaccine covered in the report are as follows:
 
 1. Fluzone High–Dose
 2. Fluzone Quadrivalent
 3. Intradermal (ID) Trivalent
 4. Vaxigrip
 5. Fluarix Quadrivalent
 6. Flulaval Quadrivalent
 7. Fluenz Tetra
 8. FluMist Quadrivalent
 9. Flublok
 10. VN–100
 11. M–001
 12. VAX–2012Q
 13. TAK – 850
 14. Flucelvax Quadrivalent
 15. Afluria Quadrivalent
 16. Agrippal
 17. Fluad
 18. Fluvirin
 19. Fluvax
 
 Key Companies Covered in the Report are as follows
 
 1. Sanofi Pasteur
 2. GlaxoSmithKline(GSK)
 3. Seqirus
 4. AstraZenecca
 5. Protein Sciences Corporation
 6. Novavax
 7. Daiichi–Sankyo
 8. Mitsubishi Tanabe Pharma
 9. BiondVax Pharmaceuticals Ltd
 10. VaxInnate
  

 1. Executive Summary
 
 2. United States Influenza Vaccine Market & Forecast
 
 3. United States Number of Persons Vaccinated with Influenza Vaccine
 3.1 Number of Children Vaccinated
 3.2 Number of Adults Vaccinated
 
 4. United States Influenza Vaccine Market Drivers and Barriers
 4.1 Market Drivers
 4.2 Market Barriers
 
 5. United States Influenza Vaccine Production & Distribution
 5.1 Vaccine Choices Remain Available for Patients, Providers
 5.2 Influenza Vaccine Price Trends
 5.2.1 Pediatric Influenza Vaccine Price Trends
 5.2.2 Adult Influenza Vaccine Price Trends
 5.3 Influenza Vaccine Production, Supply, and Allocation
 5.4 Influenza Vaccine Distribution & Demand
 5.5 Influenza Vaccine Effectiveness
 5.6 Managing Influenza with Diagnostic Resources
 5.7 Distribution Method of Influenza Vaccination
 
 6. United States Influenza Vaccine Market – Regulatory Landscape
 
 7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations
 7.1 Merger & Acquisitions
 7.2 Collaboration Deal
 7.3 Licensing, Exclusive & Distribution Agreement Deal
 7.3.1 Licensing Agreement
 7.3.2 Exclusive Agreement
 7.3.3 Distribution Agreement
 
 8. Influenza Vaccine – Pipeline Assessment
 8.1 Promising Vaccine in Clinical Development
 8.2 Promising Vaccine in Early–Stage Development
 
 9. Influenza Vaccine – Clinical Trials Assessment by Phase and Trial Status
 9.1 Year 2016
 9.2 Year 2015
 9.3 Year 2014
 9.4 Year 2013
 
 10. Key Companies Analysis
 10.1 Sanofi Pasteur
 10.1.1 Business Overview
 10.1.2 Sanofi Pasteur – Influenza Vaccine Outlook
 10.1.2.1 Fluzone High–Dose Vaccine
 10.1.2.2 Fluzone Quadrivalent Vaccine
 10.1.2.3 Intradermal (ID) Trivalent Influenza Vaccine
 10.1.2.4 Vaxigrip Vaccine
 10.1.3 Influenza Vaccine Sales Analysis
 10.2 GlaxoSmithKline (GSK)
 10.2.1 GlaxoSmithKline(GSK) – Influenza Vaccine Outlook
 10.2.1.1 Fluarix Quadrivalent
 10.2.1.2 Flulaval Quadrivalent
 10.2.2 Influenza Vaccine Sales Analysis & Forecast
 10.3 AstraZeneca
 10.3.1 Business Overview
 10.3.2 AstraZeneca – Influenza Vaccine Outlook
 10.3.2.1 Fluenz Tetra/FluMist Quadrivalent
 10.3.3 Influenza Vaccine Sales Analysis
 10.4 Protein Sciences Corporation
 10.4.1 Business Overview
 10.4.2 Protein Sciences Corporation – Influenza Vaccine Outlook
 10.4.2.1 Flublok
 10.5 Seqirus (CSL Limited)
 10.5.1 Business Overview
 10.5.2 Seqirus – Influenza Vaccine Outlook
 10.5.2.1 Flucelvax Quadrivalent
 10.5.2.2 Afluria Quadrivalent
 10.5.2.3 Agrippal
 10.5.2.4 Fluad
 10.5.2.5 Fluvirin
 10.5.2.6 Fluvax


List Of Tables

 Table 5–1: United States Influenza Vaccine Available,2016 – 17
 Table 5–2: United States – Pediatric Influenza Vaccine Price, 2016 – 2017
 Table 5–3: United States – Adult Influenza Vaccine Price, 2016 – 2017
 Table 5–4: United States – Flu Vaccine Production, Supply, and Allocation
 Table 5–5: Total Percentage of Flu Vaccines Released by Week,2016 – 2017
 Table 5–6: Total Percentage of Flu Vaccines Released by Week,2015 – 2016
 Table 5–7: Total Percentage of Flu Vaccines Released by Week,2014 – 2015
 Table 5–8: Adjusted Vaccine Effectiveness Estimates for Influenza Seasons, 2005 – 2016
 Table 5–9: Managing Influenza with Diagnostic Resources
 Table 5–10: Distribution of Influenza Vaccination
 
 Table 6–1: United States – Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
 
 Table 7–1: Influenza Vaccine Market – Merger & Acquisitions (Million US$),2003 – 2015
 Table 7–2: Influenza Vaccine Market – Collaborations Deal,2007 – 2016
 Table 7–3: Influenza Vaccine Market – Licensing Agreement,2007 – 2016
 Table 7–4: Influenza Vaccine Market – Exclusive Agreement,2009 – 2016
 Table 7–5: Influenza Vaccine Market – Distribution Agreement,2005 – 2016


List Of Figures

 Figure 2 1: United States – Influenza Vaccine Market (Million US$),2010 – 2015
 Figure 2 2: United States – Forecast for Influenza Vaccine Market (Million US$),2016 – 2022
 
 Figure 3 1: United States – Total Number of Persons Vaccinated(Thousand), 2010 – 2015
 Figure 3 2: United States – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022
 Figure 3 3: United States – Number of Children Vaccinated(Thousand),2010 – 2015
 Figure 3 4: United States – Forecast for Number of Children Vaccinated(Thousand),2016 – 2022
 Figure 3 5: United States – Number of Adults Vaccinated(Thousand),2010 – 2015
 Figure 3 6: United States – Forecast for Number of Adults Vaccinated(Thousand),2016 – 2022
 
 Figure 5 1: United States – Influenza Vaccine Doses Distributed, By Season(Million),2010 – 2016
 
 Figure 10 1: Sanofi Pasteur – Influenza Vaccine Net Sales (Million US$),2011 – 2015
 Figure 10 2: Sanofi Pasteur – Forecast for Influenza Vaccine Net Sales (Million US$),2016 – 2022
 Figure 10 3: GSK – Influenza Vaccine Net Sales (Million US$),2011 – 2015
 Figure 10 4: GSK – Forecast for Influenza Vaccine Net Sales (Million US$),2016 – 2022
 Figure 10 5: AstraZeneca – Influenza Vaccine Net Sales (Million US$),2011 – 2015


Gulf United Energy, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Gulf United Energy, Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

United States, EU, Japan, China, India and Southeast Asia Same-day Delivery Market Size, Status and Forecast 2021

Notes:Production, means the output of Same-day DeliveryRevenue, means the sales value of Same-day DeliveryThis report studies the global Same-day Delivery market, analyzes and researches the Same-day Delivery development status and

USD 3300View Report

United States Thaumatin Market Report 2016

Notes:Sales, means the sales volume of ThaumatinRevenue, means the sales value of ThaumatinThis report studies sales (consumption) of Thaumatin in United States market, focuses on the top players, with sales,

USD 3800View Report

United States, EU, Japan, China, India and Southeast Asia Same-day Delivery Market Size, Status and Forecast 2021

Notes:Production, means the output of Same-day DeliveryRevenue, means the sales value of Same-day DeliveryThis report studies the global Same-day Delivery market, analyzes and researches the Same-day Delivery development status and

USD 3300View Report

United States Thaumatin Market Report 2016

Notes:Sales, means the sales volume of ThaumatinRevenue, means the sales value of ThaumatinThis report studies sales (consumption) of Thaumatin in United States market, focuses on the top players, with sales,

USD 3800View Report

United States Sludge-suspending Agent Market Report 2016

Notes:Sales, means the sales volume of Sludge-suspendingAgentRevenue, means the sales value of Sludge-suspendingAgentThis report studies sales (consumption) of Sludge-suspendingAgent in United States market, focuses on the top players, with sales,

USD 3800View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 1000    $ 1000
  • Hard Copy $ 1100    $ 1100
  • Site Licence $ 1400    $ 1400
  • Enterprise Wide Licence $ 1400    $ 1400
$ 1000

Reports Details

Published Date : Dec 2016
No. of Pages :122
Country :United States of America
Category :Healthcare
Publisher :DPI Research
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment